BAYER AG-REG (BAYN.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:BAYN - DE000BAY0017 - Common Stock
33.395 EUR
-0.23 (-0.68%)
Overall BAYN gets a fundamental rating of 3 out of 10. We evaluated BAYN against 55 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of BAYN have multiple concerns. BAYN has a bad growth rate and is valued cheaply.
1. Profitability
1.1 Basic Checks
BAYN had positive earnings in the past year.
In the past year BAYN had a positive cash flow from operations.
In multiple years BAYN reported negative net income over the last 5 years.
BAYN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -0.19%, BAYN is doing worse than 63.64% of the companies in the same industry.
BAYN has a worse Return On Equity (-0.67%) than 63.64% of its industry peers.
BAYN has a Return On Invested Capital of 1.80%. This is in the lower half of the industry: BAYN underperforms 65.45% of its industry peers.
BAYN had an Average Return On Invested Capital over the past 3 years of 5.51%. This is significantly below the industry average of 13.92%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.19% | ||
| ROE | -0.67% | ||
| ROIC | 1.8% |
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)5.51%
ROIC(5y)N/A
1.3 Margins
BAYN has a worse Operating Margin (4.20%) than 65.45% of its industry peers.
BAYN's Operating Margin has declined in the last couple of years.
The Gross Margin of BAYN (56.35%) is worse than 70.91% of its industry peers.
In the last couple of years the Gross Margin of BAYN has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.2% | ||
| PM (TTM) | N/A | ||
| GM | 56.35% |
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BAYN is destroying value.
BAYN has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for BAYN remains at a similar level compared to 5 years ago.
Compared to 1 year ago, BAYN has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.93, we must say that BAYN is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.93, BAYN is not doing good in the industry: 72.73% of the companies in the same industry are doing better.
BAYN has a debt to FCF ratio of 10.07. This is a negative value and a sign of low solvency as BAYN would need 10.07 years to pay back of all of its debts.
BAYN has a worse Debt to FCF ratio (10.07) than 69.09% of its industry peers.
A Debt/Equity ratio of 1.11 is on the high side and indicates that BAYN has dependencies on debt financing.
With a Debt to Equity ratio value of 1.11, BAYN is not doing good in the industry: 67.27% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.11 | ||
| Debt/FCF | 10.07 | ||
| Altman-Z | 0.93 |
ROIC/WACC0.28
WACC6.4%
2.3 Liquidity
A Current Ratio of 1.14 indicates that BAYN should not have too much problems paying its short term obligations.
BAYN's Current ratio of 1.14 is on the low side compared to the rest of the industry. BAYN is outperformed by 70.91% of its industry peers.
BAYN has a Quick Ratio of 1.14. This is a bad value and indicates that BAYN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of BAYN (0.71) is worse than 78.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.71 |
3. Growth
3.1 Past
The earnings per share for BAYN have decreased by -8.72% in the last year.
The Earnings Per Share has been decreasing by -5.27% on average over the past years.
BAYN shows a decrease in Revenue. In the last year, the revenue decreased by -1.87%.
The Revenue has been growing slightly by 1.37% on average over the past years.
EPS 1Y (TTM)-8.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%137.5%
Revenue 1Y (TTM)-1.87%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.09%
3.2 Future
BAYN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.48% yearly.
The Revenue is expected to grow by 1.44% on average over the next years.
EPS Next Y-6.5%
EPS Next 2Y-1.77%
EPS Next 3Y1.82%
EPS Next 5Y3.48%
Revenue Next Year-1.37%
Revenue Next 2Y-0.26%
Revenue Next 3Y0.57%
Revenue Next 5Y1.44%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 6.25 indicates a rather cheap valuation of BAYN.
BAYN's Price/Earnings ratio is rather cheap when compared to the industry. BAYN is cheaper than 96.36% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.46. BAYN is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 6.85, the valuation of BAYN can be described as very cheap.
BAYN's Price/Forward Earnings ratio is rather cheap when compared to the industry. BAYN is cheaper than 92.73% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.10. BAYN is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.25 | ||
| Fwd PE | 6.85 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BAYN is valued a bit cheaper than the industry average as 65.45% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BAYN indicates a rather cheap valuation: BAYN is cheaper than 87.27% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.34 | ||
| EV/EBITDA | 10.42 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.77%
EPS Next 3Y1.82%
5. Dividend
5.1 Amount
With a yearly dividend of 0.36%, BAYN is not a good candidate for dividend investing.
BAYN's Dividend Yield is slightly below the industry average, which is at 2.86.
With a Dividend Yield of 0.36, BAYN pays less dividend than the S&P500 average, which is at 2.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.36% |
5.2 History
The dividend of BAYN decreases each year by -45.34%.
Dividend Growth(5Y)-45.34%
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
The earnings of BAYN are negative and hence is the payout ratio. BAYN will probably not be able to sustain this dividend level.
DP-65.15%
EPS Next 2Y-1.77%
EPS Next 3Y1.82%
FRA:BAYN (12/5/2025, 7:00:00 PM)
33.395
-0.23 (-0.68%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners48.08%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap32.81B
Revenue(TTM)45.87B
Net Income(TTM)-198.00M
Analysts71.43
Price Target29.58 (-11.42%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.36% |
Yearly Dividend0.13
Dividend Growth(5Y)-45.34%
DP-65.15%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)58.52%
Min EPS beat(2)45.89%
Max EPS beat(2)71.16%
EPS beat(4)4
Avg EPS beat(4)30.58%
Min EPS beat(4)1.86%
Max EPS beat(4)71.16%
EPS beat(8)7
Avg EPS beat(8)18.15%
EPS beat(12)9
Avg EPS beat(12)7.9%
EPS beat(16)12
Avg EPS beat(16)7.93%
Revenue beat(2)0
Avg Revenue beat(2)-2.53%
Min Revenue beat(2)-2.63%
Max Revenue beat(2)-2.42%
Revenue beat(4)1
Avg Revenue beat(4)-1.06%
Min Revenue beat(4)-2.63%
Max Revenue beat(4)1.79%
Revenue beat(8)2
Avg Revenue beat(8)-1.69%
Revenue beat(12)2
Avg Revenue beat(12)-2.67%
Revenue beat(16)6
Avg Revenue beat(16)-1.42%
PT rev (1m)1.65%
PT rev (3m)1.99%
EPS NQ rev (1m)-16.13%
EPS NQ rev (3m)-16.44%
EPS NY rev (1m)-0.56%
EPS NY rev (3m)-0.02%
Revenue NQ rev (1m)-1.99%
Revenue NQ rev (3m)-2.47%
Revenue NY rev (1m)-0.19%
Revenue NY rev (3m)-0.24%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.25 | ||
| Fwd PE | 6.85 | ||
| P/S | 0.72 | ||
| P/FCF | 8.34 | ||
| P/OCF | 4.88 | ||
| P/B | 1.11 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.42 |
EPS(TTM)5.34
EY15.99%
EPS(NY)4.87
Fwd EY14.59%
FCF(TTM)4.01
FCFY11.99%
OCF(TTM)6.84
OCFY20.49%
SpS46.69
BVpS30.11
TBVpS-18.8
PEG (NY)N/A
PEG (5Y)N/A
Graham Number60.14
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.19% | ||
| ROE | -0.67% | ||
| ROCE | 2.56% | ||
| ROIC | 1.8% | ||
| ROICexc | 2% | ||
| ROICexgc | 6.8% | ||
| OM | 4.2% | ||
| PM (TTM) | N/A | ||
| GM | 56.35% | ||
| FCFM | 8.58% |
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)5.51%
ROIC(5y)N/A
ROICexc(3y)6.21%
ROICexc(5y)N/A
ROICexgc(3y)25.79%
ROICexgc(5y)N/A
ROCE(3y)7.82%
ROCE(5y)N/A
ROICexgc growth 3Y-23.46%
ROICexgc growth 5Y-1.27%
ROICexc growth 3Y-13.2%
ROICexc growth 5Y2.54%
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
F-Score5
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.11 | ||
| Debt/FCF | 10.07 | ||
| Debt/EBITDA | 5.32 | ||
| Cap/Depr | 66.1% | ||
| Cap/Sales | 6.08% | ||
| Interest Coverage | 1.09 | ||
| Cash Conversion | 109.39% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.71 | ||
| Altman-Z | 0.93 |
F-Score5
WACC6.4%
ROIC/WACC0.28
Cap/Depr(3y)34.81%
Cap/Depr(5y)41.62%
Cap/Sales(3y)5.85%
Cap/Sales(5y)5.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%137.5%
EPS Next Y-6.5%
EPS Next 2Y-1.77%
EPS Next 3Y1.82%
EPS Next 5Y3.48%
Revenue 1Y (TTM)-1.87%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.09%
Revenue Next Year-1.37%
Revenue Next 2Y-0.26%
Revenue Next 3Y0.57%
Revenue Next 5Y1.44%
EBIT growth 1Y-2.82%
EBIT growth 3Y-16.56%
EBIT growth 5Y-3.03%
EBIT Next Year63.33%
EBIT Next 3Y21.52%
EBIT Next 5Y11.27%
FCF growth 1Y873.08%
FCF growth 3Y22.16%
FCF growth 5Y-3.69%
OCF growth 1Y161.6%
OCF growth 3Y12.83%
OCF growth 5Y-2.09%
BAYER AG-REG / BAYN.DE FAQ
What is the fundamental rating for BAYN stock?
ChartMill assigns a fundamental rating of 3 / 10 to BAYN.DE.
What is the valuation status for BAYN stock?
ChartMill assigns a valuation rating of 7 / 10 to BAYER AG-REG (BAYN.DE). This can be considered as Undervalued.
How profitable is BAYER AG-REG (BAYN.DE) stock?
BAYER AG-REG (BAYN.DE) has a profitability rating of 2 / 10.
Can you provide the expected EPS growth for BAYN stock?
The Earnings per Share (EPS) of BAYER AG-REG (BAYN.DE) is expected to decline by -6.5% in the next year.
Is the dividend of BAYER AG-REG sustainable?
The dividend rating of BAYER AG-REG (BAYN.DE) is 0 / 10 and the dividend payout ratio is -65.15%.